How SmartSignals Supplies Cut Annual Budgets for AstraZeneca & MedImmune Date Published: Apr 09, 2020 Case Study AstraZeneca & MedImmune chose Signant’s Forecasting, a web-enabled solution, to effectively forecast clinical supplies requirements and aggregate all supply and demand data into one convenient system. Although traditionally managed with independent projects or inefficient spreadsheets, clinical supply forecasting can cut costs and accelerate study startup times when in a digital format. When you choose Signant for your forecasting needs, your team will gain a live view of the supply position in each clinical trial. Learn more about the Forecasting solution and how it works. Download Now Share: LinkedInTweet Recommended Resources Article Patient-Enhanced Drug Discovery and Development This PharmaVoice article argues that patients should be viewed as partners in drug development. While big pharma companies are incorporating... Read More Article Innovations in Clinical Neuroscience: Articles on Pediatric and Orphan Disease Clinical Research Dr. Joan Busner, Signant’s Clinical Vice President and in-house expert on pediatric and orphan disease clinical trials, recently co-authored three... Download Now Do DCTs Still Offer Clinical Precision in Challenging Patient Populations? Watch Now Webinar